Open AccessSmall Molecules for Psoriasis
Author(s) -
Craig L. Leonardi
Publication year - 2016
Publication title -
seminars in cutaneous medicine and surgery
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.66
H-Index - 64
eISSN - 1558-0768
pISSN - 1085-5629
DOI - 10.12788/j.sder.2016.018
Subject(s) - medicine , tofacitinib , psoriasis , acitretin , dermatology , janus kinase inhibitor , janus kinase , rheumatoid arthritis , cytokine
Acitretin is an older, oral, non-immunosuppressive medication for the treatment of psoriasis. Tofacitinib is an oral Janus kinase inhibitor that has been studied for use in psoriasis. Each offers efficacy in certain settings and patient types but carries substantial safety risks. Semin Cutan Med Surg 35(supp4):S65-S66.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom